Questioning The Controlled Substances Act After Enmon

With the Eleventh Circuit's recent decision in United States v. Enmon, physicians continue to face two critical questions in the uncertain case law under the federal Controlled Substances Act. First, what conduct...

Already a subscriber? Click here to view full article